Temozolomide in Treating Patients With Recurrent Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome
- Status
- TERMINATED
- Phase
- PHASE2
Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1
Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
- Status
- UNKNOWN
- Phase
- PHASE2
Chemotherapy in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Temozolomide in Treating Patients With Progressive Low-Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide in Treating Patients With Anaplastic Oligodendroglioma
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor
- Status
- WITHDRAWN
- Phase
- PHASE2
Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2